TARS - NASDAQ

Tarsus Pharmaceuticals, Inc.

TARS·NASDAQ

$58.76

-0.29%

HealthcareBiotechnology

Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. The company is also developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. In addition, the company develops lotilaner to address diseases across therapeutic categories in human medicine, including eye care, dermatology, and other diseases. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$2.53B

EPS-1.5900

P/E Ratio-36.96

Earnings Date08/05/2026

tars

Other Payables

Last Annual Value

1.81M

3-Year CAGR

5-Year CAGR

10-Year CAGR

Adjust for Inflation

Tarsus Pharmaceuticals, Inc. Competitors Analysis of Other Payables

TARS · NASDAQ

Company	Other Payables	CAGR 3Y	CAGR 5Y	CAGR 10Y
Tarsus Pharmaceuticals, Inc. NASDAQ:TARS	1.81M	40.4%	101.1%	N/A
Celcuity Inc. NASDAQ:CELC	0.00	N/A	N/A	N/A
Arcutis Biotherapeutics, Inc. NASDAQ:ARQT	0.00	N/A	N/A	N/A
Legend Biotech Corporation NASDAQ:LEGN	103.10M	40.0%	26.0%	N/A
Adaptive Biotechnologies Corporation NASDAQ:ADPT	0.00	N/A	N/A	N/A
CG Oncology, Inc. Common stock NASDAQ:CGON	0.00	N/A	N/A	N/A
Disc Medicine, Inc. NASDAQ:IRON	0.00	N/A	N/A	N/A
Scholar Rock Holding Corporation NASDAQ:SRRK	0.00	N/A	N/A	N/A
Travere Therapeutics, Inc. NASDAQ:TVTX	0.00	N/A	N/A	N/A

Tarsus Pharmaceuticals, Inc. Fair Value Envelope

TARS · NASDAQ

Our analysis suggests that TARS has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $58.76, this represents a potential HIDDEN relative to our calculated worth for Tarsus Pharmaceuticals, Inc..

HIDDEN

Intrinsic Value

Current Price: $58.76

Related Guides

Blog Categories

Continue your TARS research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.